Aim
Pancreatic cancer is the third leading cause of cancer death in Australia and has a five-year survival rate of 11.5%. Significant clinical, psychological, and social burdens contribute to the poor outcomes experienced by Australians affected by pancreatic cancer. In March 2020, Cancer Australia was invited to work with key stakeholders to develop the National Pancreatic Cancer Roadmap. The aim was to identify key priorities for collaborative action across the pancreatic cancer care continuum to improve survival and outcomes for Australians affected by pancreatic cancer.
Methods
The Roadmap was developed through an evidence-based, collaborative and consensus approach, this included:
Results
The Roadmap identified 33 priorities for collective action. These priority areas cover prevention, early detection, diagnosis, treatment, supportive and palliative care, and pancreatic cancer research. Seven early implementation priorities are underway: Two relating to research (in partnership with MRFF) and five relating to 1) enhanced awareness 2) surveillance, 3) early detection, 4) defined pathways for rapid access to pain management and palliative care, 5) culturally responsive models of care.
Conclusion
Collaborative investment and implementation of the Roadmap’s priorities provides opportunities for national transformational change. Designing implementation for priority populations with a focus on equitable outcomes will enable improvements for all Australians affected by pancreatic cancer.